Quarterly report pursuant to Section 13 or 15(d)

Recapitalization - Schedule of Net current assets (Details)

v3.22.2.2
Recapitalization - Schedule of Net current assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Sep. 16, 2022
Dec. 31, 2021
Cash and cash equivalents $ 171,532   $ 92,302
Marketable securities $ 72,949   $ 38,067
Tyme Therapeutics, Inc.      
Cash and cash equivalents   $ 14,898  
Marketable securities   52,220  
Prepaid expenses   1,350  
Total   $ 68,468